Kisqali 600 MG daily dose 63S
Ended Awarded
- Contract number
- SPE2DX25FVJZM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $184,127
Award facts
- Contract value 100% obligated
- $184,127.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $184,127.05 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, for the supply of Kisqali 600 mg daily dose tablets (63-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 17, 2025. The contract is being performed from the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards involving competitively awarded delivery orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Kisqali, a breast cancer treatment medication, falls within the company's established capability to supply specialty pharmaceuticals to support military and federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DX25FVJZM?
SPE2DX25FVJZM was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 16, 2025.
How much is contract SPE2DX25FVJZM worth?
The government has obligated $184,127 on SPE2DX25FVJZM.
Is contract SPE2DX25FVJZM an order under another contract?
Yes. SPE2DX25FVJZM is a delivery order under SPE2DX15D1022, an indefinite delivery contract.
Was contract SPE2DX25FVJZM competed?
The extent of competition for SPE2DX25FVJZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award